Selective antimetastatic treatment--current status and future prospects.
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D003520:Cyclophosphamide / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007939:Leukemia L1210 / Q000188:drug therapy; D008175:Lung Neoplasms / Q000098:blood supply / Q000188:drug therapy; D008207:Lymphatic Metastasis; D051379:Mice; D008815:Mice, Inbred Strains; D008954:Models, Biological; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D009366:Neoplasm Seeding; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D009360:Neoplastic Cells, Circulating; D011092:Polyethylene Glycols / Q000627:therapeutic use; D051381:Rats; D011929:Razoxane / Q000494:pharmacology; D012673:Semustine / Q000494:pharmacology
D012673:Semustine; D011092:Polyethylene Glycols; D011929:Razoxane; D003520:Cyclophosphamide